Johannes Foßelteder

5PUBLICATIONS
29CO-AUTHORS
Haematological tumoursMolecular targetsMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 19, 2026
Mutant TP53 allelic states in human hematopoietic stem and progenitor cells.

|Jan 02, 2026
Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.

Chloe A L Thompson-Peach, Daniel Thomas, Mara Dottore

|Sep 06, 2023
BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis.

Tommaso Sconocchia, Johannes Foßelteder, Lisa Auinger

|Feb 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.

Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia

|Feb 14, 2022
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.

Denis Tvorogov, Chloe A L Thompson-Peach, Johannes Foßelteder

Pageof 1

Frequent Collaborators

5 joint publications

Andreas Reinisch

3 joint publications

Albert Wölfler

3 joint publications

Armin Zebisch

3 joint publications

Heinz Sill